02 Apr 2014, BioSpectrum Bureau , BioSpectrum
Singapore: Dr Reddy's Laboratories Limited is planning to make a fresh foray into the Japanese market.
"We are exploring all options in the sense we have product profile. The priority is to get into the right plan to enter into the (Japanese) market," DRL Vice-Chairman and Managing Director, K Satish Reddy reportedly said.
Earlier in June, Indian drug-maker and Fujifilm Corporation decided to terminate the MoU to enter into an exclusive partnership in the generic drugs business for the Japanese market.
DRL and Fujifilm signed the MoU on July 28, 2011 and the two companies had conducted detailed studies on establishment of a joint venture for developing and manufacturing generic drugs in Japan.